LENSAR, Inc. - Common Stock (NQ:LNSR)

6.480 -0.030 (-0.46%)

Delayed Quote Updated: 1:39 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about LENSAR, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

LENSAR Reports Second Quarter 2023 Results and Provides Business Update

August 09, 2023

From LENSAR, Inc.

Via Business Wire

LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups

July 24, 2023

From LENSAR, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 20, 2023

Via Benzinga

Earnings Preview For LENSAR ↗

May 12, 2023

Via Benzinga

LENSAR Earnings Perspective: Return On Capital Employed ↗

March 17, 2023

Via Benzinga

A Preview Of LENSAR's Earnings ↗

March 15, 2023

Via Benzinga

LENSAR Earnings Perspective: Return On Capital Employed ↗

December 13, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 31, 2023

Via Benzinga

LENSAR Reports First Quarter 2023 Results and Provides Business Update

May 15, 2023

From LENSAR, Inc.

Via Business Wire

LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

May 10, 2023

From LENSAR, Inc.

Via Business Wire

LENSAR: Q2 Earnings Insights ↗

August 08, 2022

LENSAR (NASDAQ:LNSR) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

March 16, 2023

From LENSAR, Inc.

Via Business Wire

LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

March 09, 2023

From LENSAR, Inc.

Via Business Wire

LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results

February 14, 2023

From LENSAR, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

December 13, 2022

On Tuesday, 49 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

During Wednesday's session, 107 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

November 28, 2022

On Monday, 79 companies reached new 52-week lows.

Via Benzinga

LENSAR to Present at Two Upcoming Investor Conferences

November 22, 2022

From LENSAR, Inc.

Via Business Wire

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update

November 09, 2022

From LENSAR, Inc.

Via Business Wire

LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022

November 02, 2022

From LENSAR, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

November 01, 2022

On Tuesday, 85 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 09, 2022

During Friday's session, 41 companies made new 52-week lows.

Via Benzinga

LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU

September 08, 2022

From LENSAR, Inc.

Via Business Wire

LENSAR Earnings Perspective: Return On Capital Employed ↗

August 30, 2022

LENSAR (NASDAQ:LNSR) brought in sales totaling $8.04 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 1.27%, resulting in a loss of $6.76 million.

Via Benzinga

First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System

August 16, 2022

From LENSAR, Inc.

Via Business Wire

LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update

August 08, 2022

From LENSAR, Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.